Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Первый МГМУ им. И.М.Сеченова
Список исп. литературыСкрыть список 1. Дороженок И.Ю. Психодерматология (психосоматические аспекты хронических дерматозов). Обзор литературы. Часть 1. Психич. расстройст. в общ. мед. 2008; 1. 2. Матюшенко Е.Н. Провоцированные акне психические расстройства. Антибиот. и химиотер. (Спецвыпуск) 2009; 3–4: 181–2. 3. Матюшенко Е.Н. Нозогенные психические расстройства у пациентов с угревой болезнью. Психич. расстройст. в общ. мед. 2009; 2: 32–5. 4. Дороженок И.Ю. Психические расстройства при атопическом дерматите. Антибиот. и химиотер. (Спецвыпуск) 2009; 3–4: 182–3. 5. Смулевич А.Б., Волель Б.А., Медведев В.Э., Терентьева М.А. Развития личности при соматических заболеваниях (к проблеме нажитой ипохондрии). Психич. расстройст. в общ. мед. 2008; 2: 4–10. 6. Смулевич А.Б., Иванов О.Л., Львов А.Н., Дороженок И.Ю. Психодерматология: современное состояние проблемы. Журн. неврол. и психиатр. 2004; 11: 4–14. 7. Смулевич А.Б., Львов А.Н. К проблеме классификации психических расстройств в дерматологии. Психич. расстройст. в общ. мед. 2008; 1: 4–7. 8. Терентьева М.А., Белоусова Т.А. Психогенные (нозогенные) расстройства при хронических дерматозах. Психиатр. и психофармакотер. 2004; 6: 270–2. 9. Akay A, Pekcanlar A, Bozdag KE et al. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Euro Acad Dermatol Venereol 2002; 16: 347–52. 10. Bahmer JA. Chronische Dermatosen und Per-sönlichkeitsstrukturen. Dt Derm 2005; 5: 317–9. 11. Bahmer JA, Kuhl J Bahmer FA. How do personality systems interact in patients suffering from psoriasis, atopic dermatitis and urticaria? Acta Derm Venereol 2007. 12. Ben-Tovim D, Walker MK. Body image, disfigurement and disability. J Psychosom Res 1995; 39: 283–91. 13. Chaput JC, Paynard T, Noveau S et al. Psoriasis, alcohol and liver disease. BMJ 1985; 291: 25. 14. Cohen AD, OfekeShlomai A, Vardy DA et al. Depression in dermatological patients identified by the Mini International Neuropsychiatric Interview questionnaire. J Am Acad Dermatol 2006; 54: 94–9. 15. Consoli SM, Rolhion S, Martin C et al. Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology 2006; 212: 128–36. 16. Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Euro Acad Dermatol Venereol 2000; 14: 267–71. 17. Esposito M, Saraceno R, Giunta A et al. An Italian study on psoriasis and depression. Dermatology 2006; 212: 123–7. 18. Fortune DG, Main CJ, O’Sullivan TM, Griffiths CEM. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755–60. 19. Fortune DG, Richards HL, Corrin A et al. Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis. J Behav Med 2003; 26: 211–24. 20. Fortune DG, Richards HL, Kirby B et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752–6. 21. Fortune DG, Richards HL, Kirby B et al. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients’ well-being. Br J Dermatol 2004; 151: 1219–26. 22. Fortune DG, Richards HL, Main CJ, Griffiths CEM. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41: 157–74. 23. Ginsburg IH, Link BG. Feelings of stigmatisation in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53–63. 24. Gupta MA, Gupta AK, Chandarana PC, Johnson AM. Dissociative symptoms and stlf-induced dermatoses: a preliminary empirical study. Psychosom Med 2000; 62: 116. 25. Gupta MА. Psychiatric сomorbidity in dermatologic disorders. In: C.Walker, L.Papadopoulos. Psychodermatology. Cambridge, 2005; 158: 29–43. 26. Gupta MA, Gupta AK The psoriasis life stress inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995; 75: 240–3. 27. Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis 1998; 61: 339–42. 28. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatological patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846–50 29. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997; 36 (4): 259–62. 30. Hill L, Kennedy P. The role of coping strategies in mediating subjective disability in people who have psoriasis. Psychol Health Med 2002; 7: 261–9. 31. Hughes J, Barraclough B, Hamblin L, White J. Psychiatric symptoms in dermatology patients. Br J Psychiat 1983; 143: 51–4. 32. Kalick S, Goldwyn R, Noe J. Social issues and body image concerns of port wine stain patients undergoing laser therapy. Lasers in Surgery and Medicine, 1981; 1: 205–13. 33. Kent G, Keohane S. Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience. Br J Clin Psychol 2001; 40: 339–42. 34. Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient membership survey. Arch Dermatol 2001; 137: 280–4. 35. Pennebaker JW, Zech E, Rime B: Disclosing and sharing emotion: psychological, social, and health consequences. In: Handbook of Bereavement Research. Ed. M.Stroebe et al. Washington, 2001. 36. Picardi A, Abeni D: Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001; 70: 118–36. 37. Picardi A, Mazotti E, Gaetano P, Cattaruzza MS. Stress, Social Support, Emotional Regulation, and Exacerbation of Diffuse Plaque Psoriasis. Psychosomatics 2005; 46: 6. 38. Poikolainen K, Reunala I, Karvonen J. Smoking, alcohol, and life events related to psoriasis among women. Br J Dermatol 1994; 130: 473–7. 39. Poikolainen K, Reunala T, Karvonen J. Alcohol intake: a risk factor for psoriasis in young and middle-aged men? BMJ 1990; 28: 780–8. 40. Rapp S, Feldman S, Exum M et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401–7. 41. Richards HL, Fortune DG, Main CJ, Griffiths CEM. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001; 50: 10–5. 42. Sampogna F, Chren MM, Melchi CF et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006; 154: 325–31. 43. Scharloo M, Kaptein AA, Weinman J et al. Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 2000; 142: 899–907. 44. Schmid-Ott G, Malewski P, Künsebeck HW et al. Krankheitsbezogener Streß bei der Psoriasis vulgaris. Validierung des «Psoriasis-Alltagsstreß-Inventars» (PAI). Hautarzt 2000; 51: 496–501. 45. Schmid-Ott G, Burchard R, Niederauer HH et al. Stigmatisierungsgefühl und Lebensqualität bei Patienten mit Psoriasis und Neurodermitis. Hautarzt 2003; 54: 852–7. 46. Schmid-Ott G, Jaeger B, Kuensebeck H et al. Dimensions of stigmatisation in patients with psoriasis in a questionnaire on experience with skin complaints. Dermatology 1996; 193: 304–10. 47. Schneider G, Hockmann J, Stander S et al. Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study. Br J Dermatol 2006; 154: 61–6. 48. Thompson A. Coping with chronic cutaneous disorders. In: C.Walker, L.Papadopoulos. Psychodermatology. Cambridge, 2005. 49. Vardy D, Besser A, Amir M et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002; 147: 736–42. 50. Wolkenstein P, Grob JJ, Bastuji-Garin S et al. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol 2003; 139: 1614–9. 51. Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry 1997; 19 (1): 29–35.